These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

75 related articles for article (PubMed ID: 4080804)

  • 1. Bioavailability studies of calcium dobesilate--a case of flip-flop kinetics.
    Franke G; Schneider T; Siegmund W; Scherber A
    Pharmazie; 1985 Aug; 40(8):562-3. PubMed ID: 4080804
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacokinetics of calcium dobesilate in beagle dogs after a single administration.
    Plessas CT; Karayannakos P; Plessas ST; Costakis A; Donta I; Skalkeas G
    Eur J Drug Metab Pharmacokinet; 1986; 11(4):303-8. PubMed ID: 3582425
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Absolute bioavailability of quinine formulations in Nigeria.
    Babalola CP; Bolaji OO; Ogunbona FA; Ezeomah E
    Afr J Med Med Sci; 2004 Sep; 33(3):185-9. PubMed ID: 15819461
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Absolute and relative bioavailability of the HMG-CoA reductase inhibitor cerivastatin.
    Mück W; Ritter W; Ochmann K; Unger S; Ahr G; Wingender W; Kuhlmann J
    Int J Clin Pharmacol Ther; 1997 Jun; 35(6):255-60. PubMed ID: 9208342
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacokinetics of tiapride and absolute bioavailability of three extravascular forms.
    Rey E; d'Athis P; Richard MO; de Lauture D; Olive G
    Int J Clin Pharmacol Ther Toxicol; 1982 Feb; 20(2):62-7. PubMed ID: 7061180
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacokinetics of calcium dobesilate in beagle dogs after repeated administration.
    Plessas CT; Karayannakos P; Plessas ST; Costakis A; Donta I; Skalkeas G
    Eur J Drug Metab Pharmacokinet; 1986; 11(4):309-12. PubMed ID: 3582426
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Absolute bioavailability of paracetamol after oral or rectal administration in healthy volunteers.
    Eandi M; Viano I; Ricci Gamalero S
    Arzneimittelforschung; 1984; 34(8):903-7. PubMed ID: 6548636
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Complete bioavailability and lack of food-effect on pharmacokinetics of gliclazide 30 mg modified release in healthy volunteers.
    Delrat P; Paraire M; Jochemsen R
    Biopharm Drug Dispos; 2002 May; 23(4):151-7. PubMed ID: 12015789
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacokinetics of tramadol and bioavailability of enteral tramadol formulations. 3rd Communication: suppositories.
    Lintz W; Barth H; Osterloh G; Schmidt-Böthelt E
    Arzneimittelforschung; 1998 Sep; 48(9):889-99. PubMed ID: 9793614
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacokinetics and bioavailability of metronidazole after tablets, suppositories and intravenous administration.
    Bergan T; Leinebo O; Blom-Hagen T; Salvesen B
    Scand J Gastroenterol Suppl; 1984; 91():45-60. PubMed ID: 6588489
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bioavailability of two oral suspension and two oral tablet formulations of acyclovir 400 mg: two single-dose, open-label, randomized, two-period crossover comparisons in healthy Mexican adult subjects.
    Palma-Aguirre JA; Absalón-Reyes JA; Novoa-Heckel G; de Lago A; Oliva I; Rodríguez Z; González-de la Parra M; Burke-Fraga V; Namur S
    Clin Ther; 2007 Jun; 29(6):1146-52. PubMed ID: 17692728
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Absolute and relative bioavailability of lithium dosage forms in the beagle dog.
    Banarer M; Ritschel WA
    Arzneimittelforschung; 1982; 32(4):383-8. PubMed ID: 6896645
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Study on the absolute bioavailability of quinine and theophylline from tablets after single dose oral administration as compared to intravenous infusion in healthy male non-smoking volunteers.
    Fuder H; Herzog R; Vaupel W; Wetzelsberger N; Lücker PW
    Methods Find Exp Clin Pharmacol; 1994 Nov; 16(9):651-60. PubMed ID: 7746027
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bioavailability of repaglinide, a novel antidiabetic agent, administered orally in tablet or solution form or intravenously in healthy male volunteers.
    Hatorp V; Oliver S; Su CA
    Int J Clin Pharmacol Ther; 1998 Dec; 36(12):636-41. PubMed ID: 9877000
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Relative bioavailability of griseofulvin lyophilized dry emulsion tablet vs. immediate release tablet: a single-dose, randomized, open-label, six-period, crossover study in healthy adult volunteers in the fasted and fed states.
    Ahmed IS; Aboul-Einien MH; Mohamed OH; Farid SF
    Eur J Pharm Sci; 2008 Oct; 35(3):219-25. PubMed ID: 18675344
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacokinetics of tramadol and bioavailability of enteral tramadol formulations. 2nd communication: drops with ethanol.
    Lintz W; Barth H; Becker R; Frankus E; Schmidt-Böthelt E
    Arzneimittelforschung; 1998 May; 48(5):436-45. PubMed ID: 9638309
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vitro and in vivo evaluation of a fast-disintegrating lyophilized dry emulsion tablet containing griseofulvin.
    Ahmed IS; Aboul-Einien MH
    Eur J Pharm Sci; 2007 Sep; 32(1):58-68. PubMed ID: 17628451
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Absolute and relative bioavailability of fentanyl buccal tablet and oral transmucosal fentanyl citrate.
    Darwish M; Kirby M; Robertson P; Tracewell W; Jiang JG
    J Clin Pharmacol; 2007 Mar; 47(3):343-50. PubMed ID: 17322146
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Calcium dobesilate, hemorheology, fibrinolysis and endothelium. New perspectives on the prevention of diabetic microangiopathy. Clinical pharmacological study].
    Guerrini M; Pieragalli D; Acciavatti A; Galigani C; Guideri F; Franchi M; Landini F; Burresi A; Messa GL; Frigerio C
    Clin Ter; 1989 May; 129(4):271-85. PubMed ID: 2527121
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Absolute bioavailability of amezinium. A cross-over study after i.v. and p.o. application.
    Kaumeier S; Kehrhahn OH; Morgenthaler H; Neugebauer G
    Arzneimittelforschung; 1981; 31(9a):1653-7. PubMed ID: 7197980
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.